Hyperkalemia and acute kidney injury with spironolactone use among patients with heart failure
Objective To quantify the risk of hyperkalemia and acute kidney injury (AKI) when
spironolactone use is added on to loop diuretic use among patients with heart failure, and to …
spironolactone use is added on to loop diuretic use among patients with heart failure, and to …
[HTML][HTML] Hyperkalemia in ambulant postcardiac surgery patients during combined therapy with angiotensin-converting enzyme inhibitor, spironolactone, and diet rich …
A Dixit, G Majumdar, P Tewari - Annals of Cardiac Anaesthesia, 2019 - journals.lww.com
Conclusion: In India, many patients are from a low socioeconomic background and often
resort to cheap and filling food items like bananas. This dietary factor should be kept in mind …
resort to cheap and filling food items like bananas. This dietary factor should be kept in mind …
Complete inhibition of the renin–angiotensin–aldosterone system; where do we stand?
SS Chen, SL Seliger, LF Fried - Current Opinion in Nephrology …, 2014 - journals.lww.com
Current evidence supports avoiding dual renin–angiotensin–aldosterone system blockade
in patients with chronic kidney disease. Subsequent studies of dual renin–angiotensin …
in patients with chronic kidney disease. Subsequent studies of dual renin–angiotensin …
Expanding role of mineralocorticoid receptor antagonists in the treatment of heart failure
A Talatinian, SL Chow… - … : The Journal of Human …, 2012 - Wiley Online Library
Despite numerous pharmacologic and nonpharmacologic treatment strategies, heart failure
remains a complex, progressive disorder with significant morbidity and mortality …
remains a complex, progressive disorder with significant morbidity and mortality …
Aldosterone antagonists in systolic heart failure
AJ Lindblad, GM Allan - Canadian Family Physician, 2014 - cfp.ca
• RALES1: an RCT of 1663 patients with class III or IV HF taking ACEIs and diuretics;
patients received spironolactone or placebo. Results at 24 months:-A statistically significant …
patients received spironolactone or placebo. Results at 24 months:-A statistically significant …
Current awareness: Pharmacoepidemiology and drug safety
John Wiley & Sons, Ltd. - 2003 - Wiley Online Library
In order to keep subscribers up‐to‐date with the latest developments in their field, John
Wiley & Sons are providing a current awareness service in each issue of the journal. The …
Wiley & Sons are providing a current awareness service in each issue of the journal. The …
[PDF][PDF] THE EFFECT OF SPIRONOLACTONE ON SERUM ELECTROLYTES AND RENAL FUNCTION TESTS IN PATIENTS WITH SEVERE CHRONIC HEART …
SA Almedeny, JY Al-Mayah… - Wiadomosci lekarskie …, 2021 - researchgate.net
The aim: To evaluate the effect of single daily 25 mg of spironolactone on serum electrolytes
and kidney function tests in patients with severe chronic left sided heart failure. Materials …
and kidney function tests in patients with severe chronic left sided heart failure. Materials …
Management of hyperkalaemia in acute kidney injury in a heart failure patient with patiromer
J Slawik, J Dederer, I Kindermann… - ESC Heart Failure, 2020 - Wiley Online Library
Aims One prevalent comorbidity of chronic heart failure (CHF) is chronic kidney disease
(CKD). Hyperkalemia is associated with both CHF and CKD, which often leads to withdrawal …
(CKD). Hyperkalemia is associated with both CHF and CKD, which often leads to withdrawal …
14. Severe electrolyte disorders after overdosing of furosemide, spironolactone and captopril in infants with congenital heart defects: A case series
DTH Van, BTK Ngoc - Tạp chí Nghiên cứu Y học, 2022 - tapchinghiencuuyhoc.vn
Congenital heart defects are common congenital defects and they are major causes of death
in those with congenital malformation. 1, 2 Heart failure is a common complication thus all …
in those with congenital malformation. 1, 2 Heart failure is a common complication thus all …
STUDIUM INTERAKCÍ LÉČIV S ENZYMY METABOLISMU CIZORODÝCH LÁTEK
K Krasulová - 2021 - dspace.cuni.cz
Cílem předložené disertační práce bylo zhodnotit interakce optických isomerů vybraných
chirálních léčiv s devíti formami nejdůležitějšího enzymatického aparátu metabolismu …
chirálních léčiv s devíti formami nejdůležitějšího enzymatického aparátu metabolismu …